Open AccessP1150: REAL WORLD DATA ON BORTEZOMIB‐BASED THERAPY IN WALDENSTRÖM'S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK‐INHIBITORS
Author(s) -
Uppal E.,
Khwaja J.,
Rismani A.,
Kyriakou C.,
D'Sa S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847468.19439.37
Subject(s) - bortezomib , medicine , tolerability , waldenstrom macroglobulinemia , regimen , rituximab , macroglobulinemia , multiple myeloma , oncology , ibrutinib , surgery , gastroenterology , lymphoma , adverse effect , leukemia , chronic lymphocytic leukemia